Ultragenyx Pharmaceutical Inc. (RARE) Documents: SEC Filings, Investor Presentations & Press Releases

Ultragenyx Pharmaceutical Inc. (RARE) documents, SEC filings and the IR site together: 116 documents, newest first; latest 2026-08-19. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site

Date	Type	Document
2026-08-19	8-K	Form 8-K, Item 8.01
2026-08-11	8-K	Form 8-K, Item 8.01
2026-08-05	10-Q	Form 10-Q for the quarter ended Jun 30
2026-08-04	Press release	Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
2026-08-04	8-K	Form 8-K, Item 2.02 results
2026-07-28	Press release	Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
2026-05-18	8-K	Form 8-K, Item 5.02
2026-05-06	10-Q	Form 10-Q for the quarter ended Mar 31
2026-05-05	Press release	Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update
2026-05-05	8-K	Form 8-K, Item 2.02 results
2026-04-29	Press release	Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update
2026-04-02	8-K	Form 8-K, Item 8.01
2026-03-30	8-K	Form 8-K, Item 8.01
2026-03-27	Proxy	Definitive proxy statement
2026-03-12	8-K	Form 8-K, Item 8.01
2026-02-23	8-K	Form 8-K, Item 8.01
2026-02-18	10-K	Annual report on Form 10-K, FY25
2026-02-15	Transcript	Q4 FY25 earnings call transcript
2026-02-12	8-K	Form 8-K, Item 2.02 results
2026-02-03	8-K	Form 8-K, Item 8.01
2026-01-30	8-K	Form 8-K, Item 8.01
2026-01-12	8-K	Form 8-K, Item 2.02 results
2025-12-30	8-K	Form 8-K, Item 8.01
2025-12-29	8-K	Form 8-K, Item 8.01
2025-11-05	10-Q	Form 10-Q for the quarter ended Sep 30
2025-11-04	8-K	Form 8-K, Item 2.02 results
2025-10-30	8-K	Form 8-K, Item 8.01
2025-09-08	8-K	Form 8-K, Item 8.01
2025-08-18	8-K	Form 8-K, Item 8.01
2025-08-06	10-Q	Form 10-Q for the quarter ended Jun 30
2025-08-05	8-K	Form 8-K, Item 2.02 results
2025-07-31	8-K	Form 8-K, Item 8.01
2025-07-11	8-K	Form 8-K, Item 8.01
2025-07-09	8-K	Form 8-K, Item 8.01
2025-06-27	8-K	Form 8-K, Item 8.01
2025-05-19	8-K	Form 8-K, Item 5.02
2025-05-07	10-Q	Form 10-Q for the quarter ended Mar 31
2025-05-06	8-K	Form 8-K, Item 2.02 results
2025-03-28	Proxy	Definitive proxy statement
2025-02-19	10-K	Annual report on Form 10-K, FY24

RARE overview · RARE earnings · RARE financials · RARE KPIs · RARE ownership · RARE peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.